OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Highlighted
Trial protocol
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Pharmacogenetic and Pharmacogenomics
Therapeutic drug monitoring
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
Categories:
Model
118 Publications
found
Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis.
b
Journal of acquired immune deficiency syndromes (1999)
July 1, 2020
p
HIV POCT
c
Economics
Model
A model-based economic evaluation of four newborn screening strategies for cystic fibrosis in Flanders, Belgium.
b
Acta clinica Belgica
June 1, 2020
p
Newborn Screening
c
Economics
Model
Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial.
b
Gut
April 1, 2020
p
Inflammatory Bowel Disease
c
Clinical outcomes
Economics
Model
Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s Disease: A Cost-Effectiveness Analysis in a Simulated Cohort.
b
Inflammatory bowel diseases
January 1, 2020
p
Therapeutic drug monitoring
c
Economics
Model
Placental growth factor testing for suspected pre-eclampsia: a cost-effectiveness analysis.
b
BJOG : an international journal of obstetrics and gynaecology
October 1, 2019
p
Preeclampsia
c
Economics
Model
Point-of-care HIV viral load in pregnant women without prenatal care: a cost-effectiveness analysis.
b
American journal of obstetrics and gynecology
September 1, 2019
p
HIV POCT
c
Economics
Model
Optimizing the dose in patients treated with imatinib as first line treatment for gastrointestinal stromal tumours: A cost-effectiveness study.
b
British journal of clinical pharmacology
September 1, 2019
p
Therapeutic drug monitoring
c
Economics
Model
A Cost-Effectiveness Analysis of Newborn Screening for Severe Combined Immunodeficiency in the UK.
b
International journal of neonatal screening
September 1, 2019
p
Newborn Screening
c
Economics
Model
Cost-effectiveness of newborn screening for severe combined immunodeficiency.
b
European journal of pediatrics
May 1, 2019
p
Newborn Screening
c
Economics
Model
Cost-effectiveness analysis of first-line pembrolizumab treatment for PD-L1 positive, non-small cell lung cancer in China.
b
Journal of medical economics
April 1, 2019
p
Cancer
c
Change patient management
Clinical outcomes
Model
Previous Page
1
…
5
6
7
8
9
…
12
Next Page
